FDA Warning Letter — Cipla Limited

Case 597511 — FEI 3004081307

The FDA took a Warning Letter action against Cipla Limited on February 12, 2020 (Salcette, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Cipla Limited
Date
February 12, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Salcette (India)